The report on the Global Gene Therapy Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2019 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Gene therapy includes use of DNA as a pharmaceutical agent to treat diseases. It promises to be one of the most important frontiers in medicine and a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections). In the recent scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development.
Gene therapy market is segmented by types, technology, applications, vectors and geography. On the basis of types the market is segmented into somatic gene therapy and germline gene therapy. On the basis of technology the market is further segmented by type of gene therapy, physical methods and chemical methods. On the basis of type of gene therapy the market is further segmented into ex vivo gene therapy and in vivo gene therapy. On the basis of physical methods the market is segmented into electroporation, microinjection, particle bombardment, ultrasound-mediated transfection, molecular vibration, laser irradiation, photochemical transfection. On the basis of chemical methods the market is further segmented into gene repair and replacement, gene editing by using short synthetic oligonucleotides, genome engineering by using TALENs, genome engineering by using CRISPR system, mRNA gene therapy, spliceosome mediated RNA trans-splicing. On the basis of application the market is segmented into oncology, infectious diseases, genetic disorders, cardiovascular disorders, diabetes mellitus, hypertension and neurological disorder. Based on geography the market is segmented into the North America, Europe, Asia and Rest of the World (RoW).
The growth is attributed to development in the gene silencing technology, increasing demand for gene therapy in immunodeficiency syndromes, growing popularity of DNA vaccines, and development in the nanotechnology. However, stringent regulatory laws in U.S. and Europe for gene therapy, side effects of gene therapy, Occurrence of Multigene Disorders in Gene Therapy and technical limitations are hindering the growth of this market.
The key players in this market are:
- AnGes MG, Inc
- Ark Therapeutics
- Ceregene, Inc
- Cobra Biologics
- GenVec, Inc
- Genzyme Corporation
- Vical, Inc
- Oxford BioMedica
- BioSante Pharmaceuticals
- Shenzhen SiBiono GeneTech Co., Ltd
- Transgene
SEGMENTATIONS IN REPORT:
By Type
- Somatic Gene therapy
- Germline Gene therapy
By Application
- Genetic Disorders
- Neurological Disorder
- Oncology
- Cardiovascular Disorders
- Diabetes Mellitus
- Infectious Diseases
- Hypertension
By Technology
- Ex vivo and in vivo gene therapy
- Ex vivo gene therapy
- In vivo gene therapy
- Physical methods
- Electroporation
- Microinjection
- Particle bombardment
- Ultrasound-mediated transfection
- Molecular vibration
- laser irradiation
- Photochemical transfection
- Chemical methods
- Gene repair and replacement
- Gene editing by using short synthetic oligonucleotides
- Genome engineering by using TALENs
- Genome engineering by using CRISPR system
- mRNA gene therapy
- Spliceosome mediated RNA trans-splicing
By Type of Vectors
- Viral vectors
- Retroviral vectors
- Nonviral vectors
- Artificial viral vectors
By Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World (ROW)
The Global Gene Therapy Market has been exhibited in detail in the following chapters -
Chapter 1 Gene Therapy Market Preface
Chapter 2 Executive Summary
Chapter 3 Gene Therapy Industry Analysis
Chapter 4 Gene Therapy Market Value Chain Analysis
Chapter 5 Gene Therapy Market Analysis By Type
Chapter 6 Gene Therapy Market Analysis By Application
Chapter 7 Gene Therapy Market Analysis By Technology
Chapter 8 Gene Therapy Market Analysis By Type of Vectors
Chapter 9 Gene Therapy Market Analysis By Geography
Chapter 10 Competitive Landscape Of Gene Therapy Companies
Chapter 11 Company Profiles Of Gene Therapy Industry